Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Biosimilar Market Report by Molecule (Infliximab, Insulin Glargine, Epoetin Alfa, Etanercept, Filgrastim, Somatropin, Rituximab, Follitropin Alfa, Adalimumab, Pegfilgrastim, Trastuzumab, Bevacizumab, and Others), Indication (Auto-Immune Diseases, Blood Disorders, Diabetes, Oncology, Growth Deficiency, Female Infertility, and Others), Manufacturing Type (In-house Manufacturing, Contract Manufacturing), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A497
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Biosimilar Market – Introduction
4.1 Overview
4.2 WHO and FDA Terminology on Biosimilars
4.3 Biosimilars and Generics
4.4 Biosimilars and Branded Biological Products
5 Why are Biosimilars So Lucrative?
5.1 Patent Expiry of Blockbuster Biological Drugs
5.2 Significant Price Differential between Biosimilars and Innovator Drugs
5.3 Savings for the Government and Third Party Payers
5.4 Rising Prevalence of Lifestyle Diseases
5.5 Incentives for Prescribers, Pharmacists and Patients
5.6 Emergence of New Players in Europe and Emerging Markets
5.7 Increasing Product Differentiation as Manufacturers Tie-Up with Drug Delivery Device Companies
6 Biosimilar Research, Development and Manufacturing
6.1 Research and Development: Biosimilars vs. Innovator Drugs
6.2 Manufacturing: Biosimilars vs. Innovator Drugs
7 Global Biosimilar Market
7.1 Market Overview
7.2 Historical Performance
7.3 Impact of COVID-19
7.4 Market Breakup by Segment
7.5 Market Breakup by Manufacturing Type
7.6 Market Breakup by Indication
7.7 Market Breakup by Region
7.8 Market Forecast
7.9 Biosimilar Patent Landscape
7.9.1 Patent Landscape in the US
7.9.2 Patent Landscape in Europe
7.9.3 Patent Landscape in Japan
7.10 SWOT Analysis
7.10.1 Overview
7.10.2 Strengths
7.10.3 Weaknesses
7.10.4 Opportunities
7.10.5 Threats
7.11 Value Chain Analysis
7.11.1 Characterizing the Existing Innovator Drug
7.11.2 Research and Development
7.11.2.1 Characterization of Biosimilars
7.11.2.2 Developing a Unique Cell Line
7.11.3 Product Development
7.11.3.1 Pre-Testing
7.11.3.2 Intermediary Clinical Testing (PK/PD)
7.11.3.3 Confirmatory Clinical Phase-III
7.11.4 Final Product Formulation
7.11.5 Marketing and Distribution
7.12 Porter’s Five Forces Analysis
7.12.1 Overview
7.12.2 Bargaining Power of Buyers
7.12.3 Bargaining Power of Suppliers
7.12.4 Degree of Competition
7.12.5 Threat of New Entrants
7.12.6 Threat of Substitutes
7.13 Price Analysis
7.13.1 Key Price Indicators
7.13.2 Price Trends
7.13.3 Margin Analysis
8 Market Breakup by Molecule
8.1 Infliximab
8.2 Insulin Glargine
8.3 Epoetin Alfa
8.4 Etanercept
8.5 Filgrastim
8.6 Somatropin
8.7 Rituximab
8.8 Follitropin Alfa
8.9 Adalimumab
8.10 Pegfilgrastim
8.11 Trastuzumab
8.12 Bevacizumab
8.13 Others
9 Market Breakup by Manufacturing Type
9.1 In-house Manufacturing
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Contract Manufacturing
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Indication
10.1 Auto-Immune Diseases
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Blood Disorder
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Diabetes
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Oncology
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Growth Deficiency
10.5.1 Market Trends
10.5.2 Market Forecast
10.6 Female Infertility
10.6.1 Market Trends
10.6.2 Market Forecast
10.7 Others
10.7.1 Market Trends
10.7.2 Market Forecast
11 Market Breakup by Region
11.1 Europe
11.1.1 Market Performance
11.1.2 Key Players and Biosimilars
11.1.3 Market Breakup by Country
11.1.4 Market Forecast
11.1.5 Italy
11.1.5.1 Market Performance
11.1.5.2 Key Players and Biosimilars
11.1.5.3 Market Forecast
11.1.6 Germany
11.1.6.1 Market Performance
11.1.6.2 Key Players and Biosimilars
11.1.6.3 Market Forecast
11.1.7 France
11.1.7.1 Market Performance
11.1.7.2 Key Players and Biosimilars
11.1.7.3 Market Forecast
11.1.8 United Kingdom
11.1.8.1 Market Performance
11.1.8.2 Key Players and Biosimilars
11.1.8.3 Market Forecast
11.1.9 Spain
11.1.9.1 Market Performance
11.1.9.2 Key Players and Biosimilars
11.1.9.3 Market Forecast
11.1.10 Rest of Europe
11.1.10.1 Market Performance
11.1.10.2 Market Forecast
11.2 United States
11.2.1 Current Market Trends
11.2.2 Key Players and Biosimilars
11.2.3 Market Forecast
11.3 Japan
11.3.1 Market Performance
11.3.2 Key Players and Biosimilars
11.3.3 Market Forecast
11.4 India
11.4.1 Current Market Trends
11.4.2 Key Players and Biosimilars
11.4.3 Market Forecast
11.5 South Korea
11.5.1 Current Market Trends
11.5.2 Key Players and Biosimilars
11.5.3 Market Forecast
11.6 Rest of the World
11.6.1 Current Market Trends
11.6.2 Market Forecast
12 Requirements for Setting Up a Biosimilar Manufacturing Plant
12.1 Manufacturing Process
12.2 Raw Material Requirements
12.3 Raw Material Pictures
12.4 Land and Construction Requirements
12.5 Machinery and Infrastructure Requirements
12.6 Machinery Pictures
12.7 Plant Layout
12.8 Packaging Requirements
12.9 Utility Requirements
12.10 Manpower Requirements
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Sandoz International GmbH
13.3.2 Pfizer Inc.
13.3.3 Teva Pharmaceutical Industries Limited
13.3.4 Celltrion Inc.
13.3.5 Biocon Limited
13.3.6 Samsung Biologics
13.3.7 Amgen, Inc.
13.3.8 Dr. Reddy's Laboratories Limited
13.3.9 Stada Arzneimittel Ag
List of Figures
Figure 1: Global: Biosimilar Market: Sales Value (in Billion US$), 2018-2023
Figure 2: Global: Biosimilar Market: Breakup by Molecule (in %), 2023
Figure 3: Global: Biosimilar Market: Breakup by Manufacturing Type (in %), 2023
Figure 4: Global: Biosimilar Market: Breakup by Indication (in %), 2023
Figure 5: Global: Biosimilar Market: Breakup by Region (in %), 2023
Figure 6: Global: Biosimilar Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 7: Global: Biosimilars Industry: SWOT Analysis
Figure 8: Global: Biosimilar Industry: Value Chain Analysis
Figure 9: Global: Biosimilars Industry: Porter’s Five Forces Analysis
Figure 10: Global: Biosimilar Market: Average Price Trends of Inflectra
Figure 11: Global: Biosimilar Market: Average Price Trends of Zarxio
Figure 12: Biosimilars Industry: Breakup of Profit Margins at Various Level of the Value Chain
Figure 13: Infliximab: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 14: Infliximab: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Insulin Glargine: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 16: Insulin Glargine: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Epoetin Alfa: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 18: Epoetin Alfa: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Etanercept: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 20: Etanercept: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Filgrastim: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 22: Filgrastim: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Somatropin: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 24: Somatropin: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Rituximab: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 26: Rituximab: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Follitropin Alfa: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 28: Follitropin Alfa: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Adalimumab: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 30: Adalimumab: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Pegfilgrastim: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 32: Pegfilgrastim: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Trastuzumab: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 34: Trastuzumab: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Bevacizumab: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Others: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: In-House Manufacturing: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 38: In-House Manufacturing: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Contract Manufacturing: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 40: Contract Manufacturing: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: Biosimilar Market (Autoimmune Diseases): Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: Biosimilar Market Forecast (Autoimmune Diseases): Sales Value (in Million US$), 2024-2032
Figure 43: Global: Biosimilar Market (Blood Disorders): Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: Biosimilar Market Forecast (Blood Disorders): Sales Value (in Million US$), 2024-2032
Figure 45: Global: Biosimilar Market (Diabetes): Sales Value (in Million US$), 2018 & 2023
Figure 46: Global: Biosimilar Market Forecast (Diabetes): Sales Value (in Million US$), 2024-2032
Figure 47: Global: Biosimilar Market (Oncology): Sales Value (in Million US$), 2018 & 2023
Figure 48: Global: Biosimilar Market Forecast (Oncology): Sales Value (in Million US$), 2024-2032
Figure 49: Global: Biosimilar Market (Growth Deficiency): Sales Value (in Million US$), 2018 & 2023
Figure 50: Global: Biosimilar Market Forecast (Growth Deficiency): Sales Value (in Million US$), 2024-2032
Figure 51: Global: Biosimilar Market (Female Infertility): Sales Value (in Million US$), 2018 & 2023
Figure 52: Global: Biosimilar Market Forecast (Female Infertility): Sales Value (in Million US$), 2024-2032
Figure 53: Global: Biosimilar Market (Others): Sales Value (in Million US$), 2018 & 2023
Figure 54: Global: Biosimilar Market Forecast (Others): Sales Value (in Million US$), 2024-2032
Figure 55: Europe: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 56: Europe: Biosimilar Market: Breakup by Country (in %), 2023
Figure 57: Europe: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Italy: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 59: Italy: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Germany: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 61: Germany: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: France: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 63: France: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: United Kingdom: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 65: United Kingdom: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Spain: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 67: Spain: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Rest of Europe: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 69: Rest of Europe: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: United States: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 71: United States: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Japan: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 73: Japan: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: India: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 75: India: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: South Korea: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 77: South Korea: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Others: Biosimilar Market: Sales Value (in Million US$), 2018-2023
Figure 79: Others: Biosimilar Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Biosimilar Manufacturing: Detailed Process Flow
Figure 81: Biosimilar Manufacturing Plant: Raw Materials Requirement
Figure 82: Biosimilar Manufacturing Process: Conversion Rates of Feedstocks
Figure 83: Biosimilar Manufacturing Plant: Machinery Costs (in US$)
Figure 84: Biosimilar Manufacturing Plant: Primary Packaging
Figure 85: Biosimilar Manufacturing Plant: Secondary Packaging
Figure 86: Biosimilar Manufacturing Plant: Tertiary Packaging
List of Tables
Table 1: Global: Sales and Patent Expiry of Blockbuster Biological Drugs (in Million US$), 2023
Table 2: Global: Biosimilar Market: Biosimilars Vs Innovators Drug Development
Table 3: Global: Biosimilar Market: Biosimilars Vs Biologics Manufacturing
Table 4: Global: Biosimilar Market: Key Industry Highlights, 2023 and 2032
Table 5: US: Biosimilar Market: Patent Landscape
Table 6: Europe: Biosimilar Market: Patent Landscape
Table 7: Japan: Biosimilar Market: Patent Landscape
Table 8: Global: Biosimilar Market: Price Comparison Between Biosimilar and Originator Drugs
Table 9: Global: Biosimilar Market: Breakup by Molecule (in Million US$), 2024-2032
Table 10: Global: Infliximab: Brand & Biosimilar Market Overview
Table 11: Global: Insulin Glargine: Brand & Biosimilar Market Overview
Table 12: Global: Epoetin Alfa: Brand & Biosimilar Market Overview
Table 13: Global: Etanercept: Brand & Biosimilar Market Overview
Table 14: Global: Filgrastim: Brand & Biosimilar Market Overview
Table 15: Global: Somatropin: Brand & Biosimilar Market Overview
Table 16: Global: Rituximab: Brand & Biosimilar Market Overview
Table 17: Global: Follitropin Alfa: Brand & Biosimilar Market Overview
Table 18: Global: Adalimumab: Brand & Biosimilar Market Overview
Table 19: Global: Pegfilgrastim: Brand & Biosimilar Market Overview
Table 20: Global: Trastuzumab: Brand & Biosimilar Market Overview
Table 21: Global: Bevacizumab: Brand & Biosimilar Market Overview
Table 22: Global: Biosimilar Market Forecast: Breakup by Manufacturing Type (in Million US$), 2024-2032
Table 23: Global: Biosimilar Market Forecast: Breakup by Indication (in Million US$), 2024-2032
Table 24: Global: Biosimilar Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 25: Europe: Biosimilar Market: Key Players and Biosimilars
Table 26: Italy: Biosimilar Market: Key Players and Biosimilars
Table 27: Germany: Biosimilar Market: Key Players and Biosimilars
Table 28: France: Biosimilar Market: Key Players and Biosimilars
Table 29: United Kingdom: Biosimilar Market: Key Players and Biosimilars
Table 30: Spain: Biosimilar Market: Key Players and Biosimilars
Table 31: United States: Biosimilar Market: Key Players and Biosimilar
Table 32: United States: Biosimilar Market: Launch of Expected Biosimilar
Table 33: Japan: Biosimilar Market: Key Players and Biosimilars
Table 34: India: Biosimilar Market: Key Players and Biosimilars
Table 35: South Korea: Biosimilar Market: Key Players and Biosimilar
Table 36: Biosimilar Manufacturing Plant: Manpower Requirements
Table 37: Biosimilar Market: Competitive Structure
Table 38: Global: Biosimilar Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More